Clinical Trial Update: Atorvastatin in Bronchiectasis in Patients With Pseudomonas Aeruginosa [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating atorvastatin in bronchiectasis patients with Pseudomonas aeruginosa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: University of Edinburgh | Conditions: BRONCHIECTASIS | Phase 4 | Status: COMPLETED